On Thursday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: WPX Energy, Inc. (NYSE:WPX), Discovery Laboratories Inc. (NASDAQ:DSCO), Rex Energy Corporation (NASDAQ:REXX), Stone Energy Corp. (NYSE:SGY)
WPX Energy, Inc. (NYSE:WPX), with shares declined -4.62%, closed at $10.93.
Discovery Laboratories Inc. (NASDAQ:DSCO), with shares dropped -8.76%, settled at $1.25.
Rex Energy Corporation (NASDAQ:REXX), with shares dipped -8.67%, and closed at $3.90
Stone Energy Corp. (NYSE:SGY), plummeted -8.67%, and closed at $14.11.
Latest NEWS regarding these Stocks are depicted underneath:
WPX Energy, Inc. (NYSE:WPX)
On March 11, WPX Energy, Inc. (WPX), Chief Executive Officer Rick Muncrief is planned to speak at the 43rd annual Scotia Howard Weil energy conference on Monday, March 23, at 2:30 p.m. Central. WPX stated its net revenue of $164 million for full-year 2014 and declared a 2015 investment plan of about $725 million.
WPX Energy, Inc., an independent natural gas and oil exploration and production corporation, engages in the exploitation and development of unconventional properties in the United States. The corporation focuses on exploiting natural gas reserves base and related natural gas liquids in the Piceance Basin of the Rocky Mountain region, in addition to developing and growing oil positions in the Williston Basin in North Dakota and the San Juan Basin in the southwestern United States.
Discovery Laboratories Inc. (NASDAQ:DSCO)
On March 16, Discovery Laboratories Inc. (DSCO), a specialty biotechnology Corporation dedicated to advancing a new standard in respiratory critical care, recently declared financial results for the fourth quarter ended December 31, 2014, in addition to recent business updates.
Select Additional Financial Results for the Fourth Quarter ended December 31, 2014:
During the fourth quarter of 2014, the Corporation recognized $1.0 million in grant proceed - $0.7 million of a $1.0 million award under a Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for up to $3.0 million to support the development of the Corporation’s aerosolized KL4 surfactant as a medical countermeasure to mitigate acute and chronic/late-phase radiation-induced lung injury, and $0.3 million under a $1.9 million Fast Track SBIR Grant from the NIH to support for the ongoing AEROSURF phase 2a clinical trial. Additionally, for the fourth quarter of 2014, the Corporation recognized $136,000 in proceed for sales of SURFAXIN, contrast to $106,000 in recognized proceed in the third quarter of 2014.
Operating expenses for the fourth quarter ended December 31, 2014 were $12.4 million. About $4.5 million of this amount were expenditures to support manufacturing, quality, medical affairs and commercialization activities to support SURFAXIN. Comprised of in research and development costs were: (1) activities to conduct our AEROSURF phase 2a clinical program and manufacture of capillary aerosol generator (CAG) devices and related components for preparation for the AEROSURF phase 2b clinical program; (2) investments associated with the Battelle partnership to prepare our CAG and related aerosol technologies for AEROSURF phase 3 studies and, if successful, commercialization; (3) investments in clinical, medical, and aerosolization device expertise to manage the AEROSURF clinical program and pipeline development; and (4) activities to support the NIH-funded study using aerosolized KL4 surfactant in radiation-induced lung injury.
Other expense for the quarter ended December 31, 2014 was $1.2 million which represents interest expense related to long-term debt. Of the $1.2 million, $0.7 million is cash interest expense and $0.5 million is non-cash amortization of the debt discount.
As of December 31, 2014, the Corporation had $30 million of long-term debt with principal payable in three equal annual installments starting in February 2017, subject to a potential one-year deferral of all amounts due in each of 2017 and 2018 if certain financial milestones are achieved.
As of December 31, 2014, the Corporation stated ordinary stock warrant liability of $1.3 million, related to five-year warrants issued in February 2011.These warrants are not subject to cash settlement, but they have been classified as derivative liabilities in accordance with generally accepted accounting principles because they contain anti-dilution provisions that adjust the exercise price of the warrants in certain circumstances.
The Corporation had 85.6 million and 84.6 million shares of ordinary stock outstanding as of December 31, 2014 and December 31, 2013, respectively.
Discovery Laboratories, Inc., a specialty biotechnology corporation, focuses on developing life-saving products for critical-care patients with respiratory disease and care in pulmonary medicine. Its drug technology produces a synthetic peptide-containing surfactant (KL4 surfactant), in addition to in liquid, lyophilized, and aerosolized dosage forms; and develops drug delivery technologies to enable efficient delivery of its aerosolized KL4 surfactant.
Stone Energy Corp. (NYSE:SGY)
On Wednesday, Stone Energy Corp. (SGY), declared that David H. Welch, Chairman, President and Chief Executive Officer, will be presenting at the Scotia Howard Weil 43rd Annual Energy Conference at the Roosevelt Hotel in New Orleans, LA at 3:20 p.m. Central time on Tuesday, March 24, 2015.
Stone Energy Corporation, an independent oil and natural gas corporation, engages in the attainment, exploration, exploitation, development, and operation of oil and gas properties in the Gulf of Mexico and the Appalachia region.
Rex Energy Corporation (NASDAQ:REXX)
In the start of this week, Rex Energy Corporation (REXX), an independent oil and gas exploration and production corporation, offered an operational update on the corporation’s Appalachian Basin operations.
Appalachian Basin — Moraine East Area
In the Moraine East Area, the corporation has accomplished drilling the final well of the four-well Renick pad. The four wells on the pad were drilled to an average lateral length of about 5,820 feet. The corporation anticipates to start completion operations on the four-well Renick pad at the end of March 2015.
Appalachian Basin — Warrior North Prospect, Carroll County, Ohio
As formerly declared, the corporation’s first quarter 2015 production had been constrained, in part because of involuntary production curtailments in the Warrior North Prospect due to downtime at the Blue Racer compressor station. The issue at the Blue Racer compressor station has been resolved and the corporation does not anticipate future production to be constrained in the Warrior North Prospect.
Rex Energy Corporation operates as an independent oil, natural gas liquid, and natural gas corporation in the Appalachian and Illinois basins in the United States. The corporation focuses on the Marcellus Shale, Utica Shale, and Burkett Shale drilling and exploration activities in the Appalachian Basin, in addition to on developmental oil drilling and the implementation of improved oil recovery on its properties in the Illinois Basins.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
